Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR)

计划入组 116 人 · 首次发布于 2023 年 10 月 26 日

Study of Transcatheter Aortic Valve Replacement With A² Flex and Commissural Alignment Technology in Severe Aortic Stenosis

计划入组 10 人 · 首次发布于 2024 年 12 月 6 日

Medical Education Intervention for Medical Students

计划入组 200 人 · 首次发布于 2016 年 1 月 5 日

Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences)

Medical Cannabis

Medical air

Peijia Medical Technology (Suzhou) Co.,Ltd.

China

Aethlon Medical

Vivani Medical

United States

Peijia Medical Receives NMPA Approval for TaurusTrio Transcatheter Aortic Valve System for Aortic Regurgitation Treatment

Peijia Medical's DCwire Micro Guidewire Receives First FDA 510(k) Clearance, Opening U.S. Market Entry

Peijia Medical Achieves First-Ever Profit Before Tax on Strong TAVR Growth